Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90

Journal of Cellular Physiology

Volumn 227, Issue 5, 2012, Pages 2196-2206

  Wang, Wen Bo ^a   Feng, Li Xing ^a   Yue, Qing Xi ^a   Wu, Wan Ying ^a   Guan, Shu Hong ^a   Jiang, Bao Hong ^a   Yang, Min ^a   Liu, Xuan ^a   Guo, De An ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELASTROL; HEAT SHOCK PROTEIN 90; MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER CELL CULTURE; CELL VACUOLE; CONTROLLED STUDY; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; PARAPTOSIS; PRIORITY JOURNAL;

APOPTOSIS; AUTOPHAGY; CELL CYCLE; CELL LINE, TUMOR; CYCLOHEXIMIDE; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME INHIBITORS; HELA CELLS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICROTUBULE-ASSOCIATED PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SYNTHESIS INHIBITORS; STRESS, PHYSIOLOGICAL; TRITERPENES; VACUOLES;

EID: 84862944939     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22956     Document Type: Article

References (32)

1. Allison AC, Cacabelos R, Lombardi VR, Alvarez XA, Vigo C. 2001. Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Prog Neuropsychopharmacol 25: 1341-1357.
2. Baehrecke EH. 2005. Autophagy: Dual roles in life and death? Nat Rev Mol Cell Biol 6: 505-510.
3. Brinker AM, Ma J, Lipsky PE, Raskin I. 2007. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry 68: 732-766.
4. Canter PH, Lee HS, Ernst E. 2006. A systematic review of randomised clinical trials of Tripterygium wilfordii for rheumatoid arthritis. Phytomedicine 13: 371-377.
5. Chen YQ, McMillan-Ward E, Kong JM, Israels SJ, Gibson SB. 2007. Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species. J Cell Sci 120: 4155-4166.
6. Chen TS, Wang XP, Sun L, Wang LX, Xing D, Mok M. 2008a. Taxol induces caspase-independent cytoplasmic vacuolization and cell death through endoplasmic reticulum (ER) swelling in ASTC-a-1cells. Cancer Lett 18: 164-172.
7. Chen YQ, McMillan-Ward E, Kong JM, Israels SJ, Gibson SB. 2008b. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ 15: 171-182.
8. Ding WX, Ni HM, Yin XM. 2007. Absence of Bax switched MG132-induced apoptosis to non-apoptotic cell death that could be suppressed by transcriptional or translational inhibition. Apoptosis 12: 2233-2244.
9. Erdélyi P, Borsos E, Takács-Vellai K, Kovács T, Kovács AL, Sigmond T, Hargitai B, Pásztor L, Sengupta T, Dengg M, Pécsi I, Tóth J, Nilsen H, Vértessy BG, Vellai T. 2011. Shared developmental roles and transcriptional control of autophagy and apoptosis in Caenorhabditis elegans. J Cell Sci 124: 1510-1518.
10. Fazi B, Bursch W, Fimia GM, Nardacci R, Piacentini M, Di Sano F, Piredda L. 2008. Fenretinide induces autophagic cell death in caspase-defective breast cancer cells. Autophagy 4: 435-441.
11. Gozuacik D, Kimchi A. 2004. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23: 2891-2906.
12. Guo WJ, Chen TS, Wang XP, Chen R. 2010. Taxol induces concentration-dependent apoptotic and paraptosis-like cell death in human lung adenocarcinoma (ASTC-a-1) cells. J X-ray Sci Technol 18: 293-308.
13. Karl R, Singha PK, Venkatachalam MA, Saikumar P. 2009. A novel role for MAP1 LC3 in nonautophagic cytoplasmic vacuolation death of cancer cells. Oncogene 28: 2556-2568.
14. Kroemer GL, Galluzzi P, Vandenabeele P, Abram J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nunez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G. 2009. Classification of cell death: Recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16: 3-11.
15. Lee JH, Koo TH, Yoon H, Jung HS, Jin HZ, Lee K, Hong YS, Lee JJ. 2006. Inhibition of NF-κB activation through targeting IκB kinase by celastrol, a quinine methide triterpenoid. Biochem Pharmacol 72: 1311-1321.
16. Milani M, Rzymski T, Mellor HR, Pike L, Bottini A, Generali D, Harris AL. 2009. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Res 69: 4415-4423.
17. Mimnaugh EG, Xu W, Vos M, Yuan X, Neckers L. 2006. Endoplasmic reticulum vacuolization and valosin-containing protein relocalization result from simultaneous hsp90 inhibition by geldanamycin and proteasome inhibition by velcade. Mol Cancer Res 4: 667-681.
18. Nagase M, Oto J, Sugiyama S, Yube K, Takaishi Y, Sakato N. 2003. Apoptosis induction in HL-60cells and inhibition of topoisomerase II by triterpene celastrol. Biosci Biotechnol Biochem 67: 1883-1887.
19. O'Donovan TR, O'Sullivan GC, McKenna S. 2011. Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy 7: 509-524.
20. Salminen A, Paimela T, Lehtonen M, Kaarniranta K. 2010. Celastrol: Molecular targets of Thunder God Vine. Biochem Biophys Res Commun 394: 439-442.
21. Sperandio S, de Belle I, Bredesen DE. 2000. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci 97: 14376-14381.
22. Sperandio S, Poksay K, de Belle I, Lafuente MJ, Liu B, Nasir J, Bredesen DE. 2004. Paraptosis: Mediation by MAP kinases and inhibition by AIP-1/Alix. Cell Death Differ 11: 1066-1075.
23. Sperandio S, Poksay KS, Schilling B, Crippen D, Gibson BW, Bredesen DE. 2010. Identification of new modulators and protein alterations in non-apoptotic programmed cell death. J Cell Biochem 111: 1401-1412.
24. Sreeramulu S, Gande SL, Gobel M, Schwalbe H. 2009. Molecular mechanism of inhibition of the human protein complex Hsp90-Cdc37, a kinome chaperone-cochaperone, by triterpene celastrol. Angew Chem Int Ed 48: 5853-5855.
25. Tardito S, Isella C, Medico E, Marchio L, Bevilacqua E, Hatzoglou M, Bussolati O, Franchi-Gazzola R. 2009. The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells. J Boil Chem 284: 24306-24319.
26. Wu WK, Wu YC, Yu L, Li ZJ, Sung JJ, Cho CH. 2008. Induction of autophagy by proteasome inhibitor is associated with proliferative arrest in colon cancer cells. Biochem Bioph Res Co 374: 258-263.
27. Wu YT, Tan HL, Shui GH, Bauvy C, Huang Q, Wenk RM, Ong CN, Codogno P, Shen HM. 2010. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem 285: 10850-10861.
28. Xie BS, Zhao HC, Yao SK, Zhuo DX, Jin B, Lv DC, Wu CL, Ma DL, Gao C, Shu XM, Ai ZL. 2011. Autophagy inhibition enhances etoposide-induced cell death in human hepatoma G2cells. Int J Mol Med 27: 599-606.
29. Yang H, Chen D, Cui QC, Yuan X, Dou QP. 2006. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine" is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res 66: 4758-4765.
30. Yoon MJ, Kim EH, Lim JH, Kwon TK, Choi KS. 2010. Superoxide anion and proteasomal dysfunction contribute to curcumin-induced paraptosis of malignant breast cancer cells. Free Radic Biol Med 48: 713-726.
31. Yue QX, Cao ZW, Guan SH, Liu XH, Tao L, Wu WY, Li YX, Yang PY, Liu X, Guo DA. 2008. Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network. Mol Cell Proteomics 7: 949-961.
32. Zhu K, Dunner K, McConkey DJ. 2010. Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene 29: 451-462.